| Secondary |
| Anticoagulant Therapy |
13.6% |
| Hypertension |
9.3% |
| Product Used For Unknown Indication |
9.3% |
| Pain |
8.6% |
| Prophylaxis |
7.1% |
| Thrombosis Prophylaxis |
5.7% |
| Ischaemic Stroke |
5.0% |
| Drug Exposure Via Mother |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Infection |
4.3% |
| Liver Transplant |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
| Pemphigus |
3.6% |
| Bacterial Infection |
2.9% |
| Deep Vein Thrombosis |
2.9% |
| Hiv Infection |
2.9% |
| Tuberculosis |
2.9% |
| Myelofibrosis |
2.1% |
| Bone Marrow Conditioning Regimen |
1.4% |
| Coagulopathy |
1.4% |
|
| Drug Interaction |
13.8% |
| Subcutaneous Haematoma |
10.3% |
| Epistaxis |
6.9% |
| Heparin-induced Thrombocytopenia |
6.9% |
| Hepatic Artery Thrombosis |
6.9% |
| Melaena |
6.9% |
| Metastatic Neoplasm |
6.9% |
| Ulcer |
6.9% |
| Varices Oesophageal |
6.9% |
| Hypoglycaemic Coma |
3.4% |
| Maternal Drugs Affecting Foetus |
3.4% |
| Pneumonia |
3.4% |
| Postmenopausal Haemorrhage |
3.4% |
| Pulmonary Embolism |
3.4% |
| Pyrexia |
3.4% |
| Reversible Posterior Leukoencephalopathy Syndrome |
3.4% |
| Thoracic Operation |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.2% |
| Prophylaxis |
13.4% |
| Multiple Myeloma |
10.9% |
| Thrombosis Prophylaxis |
10.4% |
| Pain |
7.4% |
| Drug Use For Unknown Indication |
7.0% |
| Diarrhoea |
3.8% |
| Hypothyroidism |
3.2% |
| Nausea |
2.9% |
| Hypertension |
2.6% |
| Constipation Prophylaxis |
2.5% |
| Abdominal Pain |
2.2% |
| Diabetes Mellitus |
2.2% |
| Diffuse Large B-cell Lymphoma |
2.2% |
| Bronchitis |
2.1% |
| Crohn's Disease |
2.0% |
| Prostate Cancer |
1.7% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Colitis Ulcerative |
1.5% |
| Constipation |
1.5% |
|
| Sepsis |
19.8% |
| Colon Cancer |
8.3% |
| Pneumonia |
6.3% |
| Renal Failure |
5.2% |
| Transplant Rejection |
5.2% |
| Urinary Tract Infection |
5.2% |
| Death |
4.2% |
| Deep Vein Thrombosis |
4.2% |
| Diarrhoea Haemorrhagic |
4.2% |
| Pericarditis |
4.2% |
| Renal Artery Stenosis |
4.2% |
| Sensory Loss |
4.2% |
| Anorectal Operation |
3.1% |
| Cerebrovascular Accident |
3.1% |
| Escherichia Sepsis |
3.1% |
| Mastoiditis |
3.1% |
| Myocardial Infarction |
3.1% |
| Neoplasm Malignant |
3.1% |
| Nephrogenic Systemic Fibrosis |
3.1% |
| Respiratory Failure |
3.1% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
19.5% |
| Dysphagia |
18.2% |
| Product Used For Unknown Indication |
13.0% |
| Bacterial Infection |
9.1% |
| Deep Vein Thrombosis |
7.8% |
| Hypertension |
6.5% |
| Pain |
6.5% |
| Ischaemic Stroke |
5.2% |
| Platelet Aggregation Inhibition |
3.9% |
| Pyrexia |
3.9% |
| Anticoagulant Therapy |
1.3% |
| Antiplatelet Therapy |
1.3% |
| Pain Management |
1.3% |
| Respiratory Tract Infection |
1.3% |
| Urinary Tract Infection |
1.3% |
|
| Drug Interaction |
45.5% |
| Hypoglycaemia |
18.2% |
| Arterial Thrombosis Limb |
9.1% |
| Blood Glucose Decreased |
9.1% |
| Hypoglycaemic Coma |
9.1% |
| Unresponsive To Stimuli |
9.1% |
|
